SPOTLIGHT: Adventrx to buy SD Pharmaceuticals

Adventrx to buy SD Pharmaceuticals
Adventrx Pharmaceuticals will buy SD Pharmaceuticals for 2.1 million Adventrx shares. Adventrx will gain rights to eight oncology and infectious disease products. Report